Home Health News I Was Wrong: We Can’t Skip Phase 3 Vaccine Trials – Forbes

I Was Wrong: We Can’t Skip Phase 3 Vaccine Trials – Forbes

4 min read
0
20

I wrote a blog post over the weekend that has generated tremendous pushback, including an op-ed in the New York Times as well as thousands of comments on Twitter.

In my previous post, I suggested that while we’re pursuing Phase 3 testing of several promising Covid-19 vaccines, we could simultaneously offer those same, unapproved vaccines to a wider community of volunteers, as long as those volunteers were fully informed. The benefits of moving quickly, I argued, would outweigh the risks.

I was wrong. After reading many of the responses to my article, some of them outlining the risks in greater detail, I have concluded that (1) the risks are greater than I presented them, and (2) the benefits are not as great as I had thought.

Recommended For You

On point (1), there are several risks that I didn’t emphasize sufficiently. One is that although phase 1 and 2 trials establish safety, they don’t tell the whole story. Phase 3 also looks at safety, and because many more subjects are involved, Phase 3 can identify less-common side effects that might still be very bad. (One example is ADE, which can make a viral illness worse than it would otherwise be.) These less-common side effects are a big risk of moving too quickly.

Another risk is that of trust: as many people pointed out on Twitter, if we expand the distribution of vaccines too quickly, and then the vaccine doesn’t work, we may seriously undermine the public’s trust in any eventual vaccine that really does work. That in turn will reduce the number of people willing to be vaccinated, which could cause serious harm to public health.

On the benefit side, my article assumed that we could quickly make millions of doses available before Phase 3 trials completed. I was wrong there too. We can and should ramp up production of vaccines before Phase 3 trials are over–and several manufacturers are doing just that, with government support. But these vaccines aren’t available in large quantities yet, and by the time they are, Phase 3 trials will be much further along.

One thing I’ve learned as a scientist is that if you get something wrong, you need to admit it, learn from the experience, and move on. I was wrong.

Disclaimer: the content on this site is my personal opinion and is independent of my affiliation with Johns Hopkins University.

Full coverage and live updates on the Coronavirus

Let’s block ads! (Why?)


Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Check Also

Sept. 27 update on COVID-19 in MN: 1,000+ new cases for third straight day – Minnesota Public Radio News

The number of newly confirmed COVID-19 cases reported in Minnesota on Sunday decreased fro…